Exploring the role of USP2-AS1 in HNSCC and its clinical significance has greatly enhanced our understanding of the molecular pathology of HNSCC and provided a potential treatment target for HNSCC. The gene discussed is USP2; the disease is head and neck squamous cell carcinoma.